Joel Greenblatt · Magic Formula: alto retorno sobre o capital a um EV/EBIT baixo
Is Arbutus Biopharma Corporation (ABUS) a Joel Greenblatt Stock?
High-quality business at a cheap price, strong Magic Formula fit.
100/100
Encaixa
3/5 critérios atendidos
Os critérios de Joel Greenblatt, aplicados a ABUS
EBIT/EV yield ≥ 10%
chave-
ROIC ≥ 25%
chave56.7%
EV/EBIT ≤ 12
-
Gross margin ≥ 30%
100.0%
Como ABUS pontua em outras estratégias
Dados financeiros ao vivo
Cap. de mercado
$682.08M
P/L (TTM)
5.1x
ROIC (TTM)
56.72%
Margem bruta
99.98%
Outras análises Joel Greenblatt
Perguntas frequentes
What is ABUS's Joel Greenblatt fit score?
ABUS scores 100/100 on our Joel Greenblatt fit engine. High-quality business at a cheap price, strong Magic Formula fit.
Does Joel Greenblatt actually own ABUS?
Our score is computed from financial fundamentals against Joel Greenblatt's published criteria. We don't claim that Joel Greenblatt personally owns or recommends ABUS.
How often is this score updated?
ABUS's Joel Greenblatt fit score is recomputed daily from the latest TTM financials. The page below shows when it was last refreshed.
Ferramenta educacional, não é consultoria de investimento. As pontuações são calculadas a partir de dados financeiros públicos contra os critérios publicados de cada estratégia de investimento. Não afirmamos que Joel Greenblatt possua ou recomende ABUS pessoalmente.
